High residual C-peptide likely contributes to glycemic control in type 1 diabetes

Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide

(2019) Charles Thivolet et al.   DIABETOLOGIA

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Residual β cell function and monogenic variants in long-duration type 1 diabetes patients

(2019) Marc Gregory Yu et al.   JOURNAL OF CLINICAL INVESTIGATION

Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM

(2018) Sabine Zenz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes

(2018) Michael R. Rickels et al.   TRANSPLANTATION

Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes

(2018) Emily K. Sims et al.   DIABETES CARE

Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes

(2017) Wei Hao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

(2016) Saba Sheikh et al.   DIABETES

Abnormalities of the Exocrine Pancreas in Type 1 Diabetes

(2015) Martha Campbell-Thompson et al.   Current Diabetes Reports

Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures

(2014) Michael R. Rickels et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Arginine is preferred to glucagon for stimulation testing of β-cell function

(2014) R. Paul Robertson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes

(2014) Michael R. Rickels et al.   DIABETES

Assessment of β-Cell Mass and α- and β-Cell Survival and Function by Arginine Stimulation in Human Autologous Islet Recipients

(2014) R. Paul Robertson et al.   DIABETES

Demonstration of an Intrinsic Relationship Between Endogenous C-Peptide Concentration and Determinants of Glycemic Control in Type 1 Diabetes Following Islet Transplantation

(2014) Augustin M. Brooks et al.   DIABETES CARE

Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis: Figure 1

(2014) Jennifer Sherr et al.   DIABETES CARE

Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

(2014) Asa K. Davis et al.   DIABETES CARE

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

(2013) J. M. Lachin et al.   DIABETES

Residual  -Cell Function 3-6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents

(2013) J. S. Sorensen et al.   DIABETES CARE

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes

(2013) J. Sherr et al.   DIABETES CARE

Characterization of residualβcell function in long-standing type 1 diabetes

(2013) Jennifer L. Sherr et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes

(2013) Meidjie Ang et al.   DIABETOLOGIA

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

(2013) Richard A. Oram et al.   DIABETOLOGIA

Improvement in Insulin Sensitivity After Human Islet Transplantation for Type 1 Diabetes

(2013) Michael R. Rickels et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus

(2013) Ana Maria Arbelaez et al.   PEDIATRIC DIABETES

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes

(2012) A. Siafarikas et al.   DIABETES CARE

Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay

(2012) L. Wang et al.   DIABETES CARE

Features of Hepatic and Skeletal Muscle Insulin Resistance Unique to Type 1 Diabetes

(2012) Bryan C. Bergman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

(2012) Ken T. Coppieters et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells

(2011) Jean-Claude Henquin   DIABETES RESEARCH AND CLINICAL PRACTICE

Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)

(2011) R. C. Loopstra-Masters et al.   DIABETOLOGIA

Insulin Reciprocally Regulates Glucagon Secretion in Humans

(2010) B. A. Cooperberg et al.   DIABETES

β-Cell Secretory Capacity and Demand in Recipients of Islet, Pancreas, and Kidney Transplants

(2010) Michael R. Rickels et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM